سامانه جستجوی جامع منابع دانشگاه علوم پزشکی جندی شاپور اهواز



عنوان مقاله کنفرانس : P49 The effects of oral cotrimoxazole upon neutrophil and monocyte activation in patients with pulmonary fibrosis and healthy controls; does this relate to its action in idiopathic pulmonary fibrosis?

ناشر : BMJ Publishing Group Ltd and British Thoracic Society

DOI کد :

10.1136/thoraxjnl-2017-210983.191

سال انتشار : 2017

نویسنده : VA Varney, B Smith, G Quirke, H Parnell, S Ratnatheepan, AS Bansal, A Nicholas

نوع : مقاله کنفرانس

لینک خروجی به مقاله کنفرانس

@incollection{1,
    doi = {10.1136/thoraxjnl-2017-210983.191},
    url = {http://dx.doi.org/10.1136/thoraxjnl-2017-210983.191},
    year = 2017,
    publisher = {BMJ Publishing Group Ltd and British Thoracic Society},
    pages = {},
    author = {VA Varney, B Smith, G Quirke, H Parnell, S Ratnatheepan, AS Bansal, A Nicholas},
    title = {P49 The effects of oral cotrimoxazole upon neutrophil and monocyte activation in patients with pulmonary fibrosis and healthy controls; does this relate to its action in idiopathic pulmonary fibrosis?}
}
TY  - DATA
DO  - 10.1136/thoraxjnl-2017-210983.191
UR  - http://dx.doi.org/10.1136/thoraxjnl-2017-210983.191
TI  - P49 The effects of oral cotrimoxazole upon neutrophil and monocyte activation in patients with pulmonary fibrosis and healthy controls; does this relate to its action in idiopathic pulmonary fibrosis?
PY  - 2017
PB  - BMJ Publishing Group Ltd and British Thoracic Society
SP  - 
AU  -VA Varney, B Smith, G Quirke, H Parnell, S Ratnatheepan, AS Bansal, A Nicholas
VA Varney, B Smith, G Quirke, H Parnell, S Ratnatheepan, AS Bansal, A Nicholas, T. (2017). P49 The effects of oral cotrimoxazole upon neutrophil and monocyte activation in patients with pulmonary fibrosis and healthy controls; does this relate to its action in idiopathic pulmonary fibrosis?. doi:10.1136/thoraxjnl-2017-210983.191
“P49 The effects of oral cotrimoxazole upon neutrophil and monocyte activation in patients with pulmonary fibrosis and healthy controls; does this relate to its action in idiopathic pulmonary fibrosis?.” (2017) - Author: VA Varney, B Smith, G Quirke, H Parnell, S Ratnatheepan, AS Bansal, A Nicholas